KCNIP3 and systemic sclerosis: Elevated DREAM expression in the skin was confirmed by immunolabeling in SSc (n = 10) compared to healthy control (n = 10) biopsies (p = 0.0009) (Cohort 2, Table 2), with concomitant elevation in procollagen I expression in the dermis (Fig. 5C).